Towards Personalized Medicine: Non-Coding RNAs and Endometrial Cancer
Endometrial cancer (EC) is the most frequent female cancer associated with excellent prognosis if diagnosed at an early stage. The risk factors on which clinical staging is based are constantly updated and genetic and epigenetic characteristics have recently been emerging as prognostic markers. The...
Main Authors: | Anna Franca Cavaliere, Federica Perelli, Simona Zaami, Roberto Piergentili, Alberto Mattei, Giuseppe Vizzielli, Giovanni Scambia, Gianluca Straface, Stefano Restaino, Fabrizio Signore |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9032/9/8/965 |
Similar Items
-
Non-Coding RNAs as Prognostic Markers for Endometrial Cancer
by: Roberto Piergentili, et al.
Published: (2021-03-01) -
Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification
by: Anna Franca Cavaliere, et al.
Published: (2021-11-01) -
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis
by: Romain Delangle, et al.
Published: (2019-06-01) -
Screening of prognostic biomarkers for endometrial carcinoma based on a ceRNA network
by: Ming-Jun Zheng, et al.
Published: (2018-12-01) -
Identification of novel cell glycolysis related gene signature predicting survival in patients with endometrial cancer
by: Zi-Hao Wang, et al.
Published: (2019-11-01)